These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2086903)

  • 1. [Clinical significance of islet cell antibody and islet cell surface antibody in diabetics].
    Iwo K
    Nihon Rinsho; 1990 Dec; 48 Suppl():300-7. PubMed ID: 2086903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmunity and viral infections in type-I diabetes mellitus].
    Helmke K; Weimer R; Willems W; Otten A; Mäser E; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1986 Mar; 111(10):369-73. PubMed ID: 3512225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].
    Ludwig H; Schernthaner G; Mayr WR
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1221-4. PubMed ID: 334498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin autoantibody].
    Uchigata Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():333-8. PubMed ID: 9434490
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics?
    Michaelis D; Rjasanowski I; Ratzmann KP; Strese J; Dietz H; Hildmann W
    Acta Biol Med Ger; 1982; 41(12):1093-8. PubMed ID: 6765149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection of human circulating islet cell surface antibodies by dispersed rat pancreatic islet cells (III). Examination of clinical significance].
    Maruyama S; Sugiura M; Tomiyama H; Aizawa T; Ishido T; Kinjyo T; Kuwae M; Mimura G
    Rinsho Byori; 1984 Mar; 32(3):291-8. PubMed ID: 6376874
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunologic aspects of diabetes mellitus].
    Esenin VI; Zlobina EN; Demin IuM; Dedov II
    Sov Med; 1990; (3):100-1. PubMed ID: 2195666
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies to the pancreatic islet cells in type-1 diabetes mellitus].
    Zlobina EN; Esenin VI; Demin IuM; Minkin SA
    Sov Med; 1988; (12):21-3. PubMed ID: 2468188
    [No Abstract]   [Full Text] [Related]  

  • 11. Islet cell antibodies and diabetes in Nigerians.
    Oli JM; Bottazzo GF; Doniach D
    Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet-cell-surface antibodies in juvenile diabetes mellitus.
    Lernmark A; Freedman ZR; Hofmann C; Rubenstein AH; Steiner DF; Jackson RL; Winter RJ; Traisman HS
    N Engl J Med; 1978 Aug; 299(8):375-80. PubMed ID: 353557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of strong association between residual human C-peptide secretion and islet cell antibodies, complement-dependent antibody-mediated cytotoxicity, and HLA antigens in newly diagnosed type I diabetics.
    Michaelis D; Rjasanowski I; Hehmke B; Kohnert KD; Hildmann W; Keilacker H; Richter KV
    Biomed Biochim Acta; 1985; 44(1):99-106. PubMed ID: 3888215
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 1 diabetes mellitus.
    Larger E; Dubois-Laforgue D
    Ann Med Interne (Paris); 1999 Apr; 150(3):254-63. PubMed ID: 10445097
    [No Abstract]   [Full Text] [Related]  

  • 15. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistry.
    Kohnert KD; Rjasanowski I; Hehmke B; Hamann J; Keilacker H; Michaelis D
    Diabetes Res; 1994; 25(1):1-12. PubMed ID: 7648777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody.
    Negishi K; Kawazu S; Ishii J; Kanazawa Y
    J Clin Lab Immunol; 1986 Apr; 19(4):155-9. PubMed ID: 3014151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S; Gastauer R; Winkler G
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance for islet autoimmunity among monozygotic twins.
    Redondo MJ; Jeffrey J; Fain PR; Eisenbarth GS; Orban T
    N Engl J Med; 2008 Dec; 359(26):2849-50. PubMed ID: 19109586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.